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Abstract: Our earlier studies found that in vitro estradiol modulates mitochondrial Ca2+ transport in discrete brain regions. The present
study examined the role of estradiol receptors (ERs) in estradiol-induced inhibition of Ca2+ efflux from synaptosomal mitochondria
isolated from rat caudate nuclei and brain stems. Radioactively labeled CaCl2 (0.6–0.75 µCi 45CaCl2) was used for Ca2+ transport
monitoring. The results revealed that in the presence of ER antagonist 7α,17β-[9[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra1,3,5(10)-triene-3,17-diol (ICI 182,780) (1 µmol/L), the inhibitory effect of estradiol on mitochondrial Ca2+ efflux was more than 60%
decreased, suggesting the involvement of ER in this mode of estradiol neuromodulatory action. When particular contributions of ERα
and ERβ were tested, it was found that ERβ agonist 2,3-bis(4-hydroxy phenyl)-propionitrile (10 nmol/L) inhibited Ca2+ efflux more than
20%, while the inhibition with ERα agonist 4,4’,4’’-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (10 nmol/L) was about 10%, both
compared to the control. Both agonists demonstrated attenuation of Ca2+ efflux decrease in the presence of mitochondrial Na+/Ca2+
exchanger antagonist 7-chloro-5-(2-chlorophenyl)-1,5-dihyhdro-4,1-benzothiazepin-2(3H)-one (10 µmol/L), showing interference
with the inhibitory action of that agent. Our results strongly indicate ERs as the mediators of estradiol-induced mitochondrial Ca2+
efflux inhibition in rat caudate nucleus and brain stem synaptosomes.
Key words: Ca2+ efflux, estradiol receptors, synaptosomal mitochondria, caudate nucleus, brain stem

1. Introduction
Estradiol exerts its physiological function by 2 main
pathways: genomic, via the transcription of certain target
genes, and nongenomic, which is independent of direct
gene activation (Stormshak and Bishop, 2008; Yu and
Chaudry, 2009). While genomic effects are quite well
described (Chen et al., 2004; Vasudevan and Pfaff, 2008),
nongenomic estradiol effects are insufficiently known and
studied. In different brain regions estradiol affects, in a
nongenomic manner, the growth of dendritic branches,
activity of GABA receptors, and the concentration of
sodium and potassium ions (Kelly et al., 2002; Kow
et al., 2006; Vasudevan and Pfaff, 2008). Modulation
of synaptosomal and mitochondrial Ca2+ transport,
previously reported from our laboratory, also relates to
rapid, nongenomic methods of estradiol action (Nikezic
et al., 1996, 1997; Horvat et al., 2000, 2001; Petrovic et al.,
2005, 2011, 2012). The estradiol receptors (ERs) ERα and
ERβ appear to be the key mediators of estradiol effects in
the brain. They are primarily localized in the cytoplasm
* Correspondence: snjezana5.imr12@yahoo.com
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and nucleus, while small amounts of ER are associated
with the cell membrane and organelles (Kisler et al., 2013).
Both receptors are present in the mitochondrial matrix,
being involved in different aspects of hormone influence.
Acting through ERα, estradiol increases mitochondrial
cytochrome c protein, mRNA, and mitochondrial aconitase
activity in brain endothelial cells (Razmara et al., 2008).
On the other hand, ERβ knockdown results in a lower
resting mitochondrial membrane potential, an increase
in resistance to oxidative stressors, and maintained ATP
concentrations in primary hippocampal neurons (Yang et
al., 2009). Results of our in vitro studies on mitochondria
isolated from hippocampal synaptosomes strongly suggest
the involvement of ER in estradiol-induced modulation of
mitochondrial Ca2+ flux (Petrovic et al., 2011). However,
obtained results do not exclude the possibility of direct
hormone action through estrogen-specific binding
sites (other than ERs) associated with mitochondrial
membranes. We already reported that specific estradiol
binding to synaptosomal mitochondria is involved in
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extragenomic hormone action on mitochondrial and
synaptosomal content of Ca2+ (Horvat et al., 2001). In
addition, estradiol showed beneficial effects on fatty acid
composition of membrane phospholipids (Petrovic et al.,
2014).
Calcium (Ca2+) transport across the plasma membrane
and membranes of subcellular organelles plays a
fundamental role in neuronal activity and functions, such
as synaptogenesis, neurite outgrowth, neurotransmitter
release, synaptic plasticity, and cell differentiation and
apoptosis. Among others, dopamine metabolism in the
caudate nucleus (NC) and the development of the auditory
brain stem also depend on Ca2+ flux regulation (Etou et
al., 1996; Hirtz et al., 2011). In these regions, as well as in
whole brain tissue, compromised Ca2+ homeostasis leads
to neuronal dysfunction and cell death, being connected
with multiple CNS disorders (Carafoli, 2002). Due to
specific Ca2+ transport mechanisms, ruthenium red (RR)sensitive uniporter for Ca2+ influx and mitochondrial Na+/
Ca2+ exchanger (mtNCX) for Ca2+ efflux mitochondria
are organelles critical for Ca2+ buffering in neural cells.
The large population of neuronal mitochondria can store
and release relatively large amounts of calcium, leading to
transient changes in the intracellular Ca2+ concentrations.
Mitochondrial damage and disturbance of mitochondrial
Ca2+ flux adversely affect the overall Ca2+ homeostasis in
the brain (Szabadkai and Duchen, 2008).
The predominant Ca2+ efflux mechanism in
synaptosomal mitochondria is the mtNCX. Estradiol was
already found to inhibit mtNCX activity and consequently
to decrease Ca2+ efflux from whole rat brain, hippocampal,
NC, and brain stem (BS) synaptosomal mitochondria
(Petrovic et al., 2012). Even more, the involvement of ER
in Ca2+ efflux inhibition from hippocampal mitochondria
has been confirmed (Petrovic et al., 2011). With this in
mind, it was hypothesized that ER can be involved in
transducing estradiol’s inhibitory effects on mitochondrial
Ca2+ efflux in 2 other brain regions, the NC and BS. Thus,
the aim of this study was to examine if, and to what
extent, ERs participate in estradiol-induced inhibition of
mitochondrial Ca2+ efflux in rat NC and BS.
2. Materials and methods
2.1. Animals
Mature, chronically (3 weeks prior to use) ovariectomized
female Wistar rats were used. The animals were obtained
from the special animal breeding unit of our laboratory
and maintained under constant conditions (lights on:
0500–1700 hours, temperature: 24 °C, free access to
food and water). All procedures were approved by the
Ethics Committee of the Serbian Association for the
Use of Animals in Research and Education and were in
accordance with the guidelines published in the 1996 NIH

Guide for the Care and Use of Laboratory Animals and
the principles presented in the ‘Guidelines for the Use
of Animals in Neuroscience Research by the Society for
Neuroscience.
2.2. Isolation of synaptosomal mitochondria
After decapitation, whole brains were removed on ice.
Synaptosomes were prepared from pools of NC and BS
(10 NCs/pool and 10 BSs/pool). Purified synaptosomal
mitochondria were isolated using a Ficoll gradient:
4.5% and 6% resolved in medium containing 0.24 mol/L
mannitol, 60 mmol/L sucrose, 50 µmol/L EDTA, and
10 mmol/L Tris-HCl (pH 7.4), as described previously
(Petrovic et al., 2011). Proteins were determined by the
method of Lowry et al. (1951) as modified by Markwell et
al. (1978).
2.3. Pharmacological agents
CaCl2 (specific activity: 16.8 mCi/mg) was purchased
from PerkinElmer (USA). Cellulose nitrate filters (pore
size: 0.45 µm) were from Whatman International (USA).
7α,17β-[9[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]
nonyl] estra-1,3,5(10)-triene-3,17-diol (ICI 182,780),
4,4’, 4’’-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol
(PPT), 2,3-bis(4-hydroxy phenyl)-propionitrile (DPN),
and
7-chloro-5-(2-chlorophenyl)-1,5-dihyhdro-4,1benzothiazepin-2(3H)-one (CGP) were obtained from
Tocris Cookson Ltd. (USA). RR, 17β-estradiol (E2),
17β-estradiol conjugated to bovine serum albumin
(E-BSA), and other chemicals were purchased from Sigma
Chemical Co. (USA).
2.4. Mitochondrial Ca2+ transport
Ca2+ transport in mitochondria isolated from NC and
BS synaptosomes was performed in the same conditions
as already published (Petrovic et al., 2012). After
preincubation at 23 °C for 10 min in a medium containing
300 mmol/L mannitol, 10 mmol/L KCl, 1 mmol/L malate,
5 mmol/L glutamate, and 10 mmol/l Tris-HCl (pH 7.4),
mitochondria (0.2 mg protein/mL in a final volume of 300
µL) were loaded with Ca2+ in the presence of 0.2 mol/L
CaCl2 (0.6–0.75 µCi 45CaCl2) for 5 min. Ca2+ influx was
stopped by RR (17.5 µg/mg protein), a specific inhibitor
of the mitochondrial Ca2+-uniporter. Aliquots of 100
µL in size were vacuum-filtered on 0.45-µm pore-size
cellulose-nitrate filters. After being washed twice with 3
mL of 0.25 M sucrose, the Ca2+ retained in mitochondria
was calculated from radioactivity counting (corrected for
blank without mitochondria and for nonspecific binding).
For Ca2+ efflux monitoring, mitochondria (0.2 mg
protein/mL in the remaining volume of 200 µL) were
incubated in the absence or presence of 0.5 nmol/L E2 or
E-BSA (E2 concentration: 0.5 nmol/L) for an additional
10 min. Ca2+ efflux was initiated by adding 100 mmol/L
NaCl and 0.2 mmol/L EDTA and lasted for 5 min.
45
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3. Results
3.1. Effect of ER antagonist ICI 182,780 on mitochondrial
Ca2+ efflux inhibition
The effects of ER antagonist ICI 182,780 on the inhibitory
effect of E2 and E-BSA on Ca2+ efflux from NC and BS
synaptosomal mitochondria are shown in Figure 1. In
control conditions, Ca2+ efflux from NC mitochondria
was 4.25 ± 0.28 nmol/mg protein. In the presence of E2,
Ca2+ efflux was reduced to 2.51 ± 0.18 nmol/mg protein
(P < 0.001, when comparing E2 to the control) and in the
presence of E-BSA to 3.36 ± 0.26 nmol/mg protein (P <
0.001 when comparing E-BSA to the control). Thus, E2
inhibited Ca2+ efflux from NC mitochondria by 41% and
E-BSA by 21%. When mitochondria were pretreated with
ICI 182,780 before E2 or E-BSA addition, an increase of
Ca2+ efflux could be seen when compared to E2 or E-BSA
alone. Ca2+ efflux measured in the presence of ICI 182,780
and E2 was 3.62 ± 0.26 nmol/mg protein (P < 0.001 when
compared ICI + E2 to E2 alone) and in the presence of ICI
182,780 and E-BSA was 4.08 ± 0.20 nmol/mg protein (P <
0.001 when comparing ICI + E-BSA to E-BSA alone). Thus,
pretreatment with ICI 182,780 decreased E2- and E-BSAinduced inhibition of Ca2+ efflux from NC mitochondria
by 64% and 81%, respectively. In the BS mitochondria,
control Ca2+ efflux was 2.63 ± 0.22 nmol/mg protein, while
E2 reduced this efflux to 1.66 ± 0.20 nmol/mg protein (P
< 0.001 when comparing E2 to the control) and E-BSA to
2.18 ± 0.13 nmol/mg protein (P < 0.001 when comparing
E-BSA to the control). Thus, E2 inhibited Ca2+ efflux from
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The process was stopped with 2 mL of 0.25 M sucrose.
Aliquots of 1 mL in size were vacuum-filtered and washed
as described above. Na+-dependent Ca2+ efflux was
calculated by subtracting the Ca2+ concentration retained
in mitochondria after Na+/EDTA addition from the Ca2+
concentration in mitochondria after addition of RR.
The effects of the estrogen receptor antagonist (ICI
182,780 (1 µmol/L)), ERα agonist (PPT (10 nmol/L)),
ERβ agonist (DPN (10 nmol/L)), and mitochondrial Na+/
Ca2+ exchanger specific antagonist (CGP (10 µmol/L)) on
Na+-dependent Ca2+ efflux in the presence and absence
of E2 were measured by incubating Ca2+-preloaded
mitochondria with ICI 182,780 for 20 min, PPT and DPN
for 10 min, or CGP for 3 min before Na+/EDTA efflux
initiation.
2.5. Statistical analysis
Changes in Ca2+ efflux observed after administering ICI
182,780, PPT, DPN, or CGP were assessed by one-way
ANOVA followed by Tukey’s post hoc test for intergroup
comparison. The values represent the mean ± SEM of at
least 3 experiments (with triplicate determinations). The
differences were considered statistically significant at P <
0.05.
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Figure 1. Prevention of E2 and E-BSA inhibitory action on Ca2+
efflux by ER antagonist ICI 182,780: a) in NC mitochondria, b) in
BS mitochondria. Ca2+-preloaded mitochondria were incubated
for 20 min in the absence or presence of 1 µmol/L ER antagonist
ICI 182,780 at 23 °C. Incubation continued for an additional
10 min in the absence or presence of 0.5 nmol/L E2 or E-BSA
(E2 concentration 0.5 nmol/L). Efflux was measured after
the addition of 100 mmol/L NaCl and 0.2 mmol/l EDTA. The
amount of released Ca2+ was estimated as indicated in Section
2. One-way ANOVA followed by Tukey’s post hoc test showed
significant decrease of Ca2+ efflux from mitochondria treated
with E2 or E-BS when compared to the control (***P < 0.001)
and significant increase of Ca2+ efflux when mitochondria were
treated with ICI 182,780 before E2 or E-BSA addition (#P < 0.001,
when comparing ICI + E2 to E2, and ICI + E-BSA to E-BSA).
The results represent the mean ± SEM of 3 experiments (with
triplicate determinations).

BS mitochondria by 37% and E-BSA by 18%. As in NC
mitochondria, pretreatment of BS mitochondria with ICI
182,780 before E2 or E-BSA addition elevated Ca2+ efflux
when compared to E2 or E-BSA alone. In the presence
of ICI 182,780 and E2, Ca2+ efflux was 2.29 ± 0.16 nmol/
mg protein (P < 0.001 when comparing ICI + E2 to E2
alone), and in the presence of ICI 182,780 and E-BSA,
Ca2+ efflux was 2.52 ± 0.20 nmol/mg protein (P < 0.001
when comparing ICI + E-BSA to E-BSA alone). Thus, ER
antagonist ICI 182,780 diminished the inhibitory effect of
E2 on Ca2+ efflux from BS mitochondria by 65% and E-BSA
by 76%. Such an effect of ER antagonist strongly suggests
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the involvement of ER in E2 and E-BSA inhibitory action
on mitochondrial Ca2+ efflux.
3.2. Effects of ERα agonist PPT and ERβ agonist DPN on
mitochondrial Ca2+ efflux inhibition
To test the assumption about the involvement of ER in
Ca2+ efflux inhibition and to examine the respective roles
of ERα and ERβ, mitochondrial Ca2+ efflux was measured
in the presence of a PPT-specific agonist of ERα and a
DPN-specific agonist of ERβ (Figure 2). PPT decreased
Ca2+ efflux from NC mitochondria by 10% (control Ca2+
efflux: 4.71 ± 0.26 nmol/mg protein; in the presence of
PPT: 4.23 ± 0.17 nmol/mg protein; P < 0.05) and from
BS mitochondria by 15% (control Ca2+ efflux: 2.36 ± 0.15
nmol/mg protein; in the presence of PPT 2.01 ± 0.13 nmol/
mg protein; P < 0.01). The inhibitory effect of DPN was
even stronger, reducing Ca2+ efflux from NC mitochondria
by 25% (Ca2+ efflux in the presence of DPN 3.53 ± 0.1
Ca2+/mg protein, P < 0.001 when compared to control)
and from BS mitochondria by 21% (Ca2+ efflux in the
presence of DPN 1.86 ± 0.17 Ca2+/mg protein, P < 0.001
when compared to control). In mitochondria from both
brain regions, NC and BS, the separate inhibitory potential
of PPT or DPN was significantly lower when compared
to E2, at P < 0.001. A significant difference between Ca2+
efflux in the presence of PPT and DPN was observed in
NC mitochondria (P < 0.001).
3.3. Effect of specific inhibitor of mitochondrial Na+/Ca2+
exchanger CGP
In addition, both ER agonists expressed their effects
in experiments with CGP, the specific inhibitor of
mtNCX (Figure 3). CGP inhibited Ca2+ efflux from NC
mitochondria by 94% (control Ca2+ efflux: 4.46 ± 0.22
nmol/mg protein; in the presence of CGP: 0.27 ± 0.045
nmol/mg protein; P < 0.001) and from BS mitochondria
by 92% (control Ca2+ efflux: 2.51 ± 0.24 nmol/mg protein;
in the presence of CGP 0.20 ± 0.075 nmol/mg protein; P <
0.001). On the other hand, the incubation of mitochondria
with ERβ agonist DPN before the addition of CGP
increased Ca2+ efflux from NC mitochondria by 2.3-fold
when compared with CGP alone. In the presence of DPN
and CGP, Ca2+ efflux was 0.62 ± 0.057 nmol/mg protein
(P < 0.001 when comparing DPN + CGP to CGP alone).
Incubation of BS mitochondria with DPN before the
addition of CGP increased Ca2+ efflux by 3.2-fold (0.64 ±
0.081 nmol/mg protein) when compared with CGP alone
(P < 0.001 when comparing DPN + CGP to CGP). ERα
agonist PPT was less effective, with a 1.5-fold Ca2+ efflux
increase from NC mitochondria, in the presence of CGP
(0.4 ± 0.091 nmol/mg protein, P < 0.001 when comparing
PPT + CGP to CGP) and almost no increase of efflux from
BS mitochondria when compared with CGP alone. In
mitochondria from both regions, a significant difference
between Ca2+ efflux in the presence of PPT + CGP and
DPN + CGP was observed at P < 0.001.

Ca 2+ efflux (nmol/mg protein)
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Figure 2. Involvement of ERα and/or ERβ in Ca2+ efflux
modulation: a) in NC mitochondria, b) in BS mitochondria.
Ca2+-preloaded mitochondria were incubated for 10 min in
the absence or presence of 0.5 nmol/L E2, 10 nmol/L selective
ERα agonist PPT, or 10 nmol/L selective ERβ agonist DPN at
23 °C. Efflux was measured after the addition of 100 mmol/L
NaCl and 0.2 mmol/L EDTA. The amount of released Ca2+ was
estimated as indicated in Section 2. One-way ANOVA followed
by Tukey’s post hoc test showed significant decrease of Ca2+
efflux from mitochondria treated with E2, PPT, or DPN when
compared to the control (for NC mitochondria the significance
was ***P < 0.001, **P < 0.05, *P < 0.001, respectively, and for BS
mitochondria ***P < 0.001, **P < 0.01, *P < 0.001, respectively);
significantly different Ca2+ efflux from PPT- or DPN-treated
mitochondria when compared to E2-treated mitochondria (#P
< 0.001); and significant decrease of Ca2+ efflux from DPNtreated NC mitochondria when compared to PPT-treated NC
mitochondria (XP < 0.001). The results represent the mean ± SEM
of 3 experiments (with triplicate determinations).

4. Discussion
In the present study, the role of mitochondrial ER in E2induced inhibition of Ca2+ efflux from synaptosomal
mitochondria isolated from rat brain NCs and BSs was
evaluated by using specific ER antagonist ICI 182,780 and
agonists PPT and DPN. We reported for the first time that
both ERα and ERβ are involved in the inhibitory effect of E2
on Ca2+ efflux from NC and BS synaptosomal mitochondria.
Estradiol is well known to affect different aspects of
mitochondrial function. By promoting mitochondrial
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Figure 3. Involvement of ERα and/or ERβ in Ca2+ efflux
modulation by mitochondrial Na+/Ca2+ exchanger inhibitor
CGP: a) in NC mitochondria, b) in BS mitochondria. Ca2+preloaded mitochondria were incubated for 10 min in the
absence or presence of 10 nmol/L selective ERα agonist PPT
or 10 nmol/L selective ERβ agonist DPN at 23 °C. Incubation
continued for an additional 3 min in the absence or presence of
10 µmol/L CGP. Efflux was measured after the addition of 100
mmol/L NaCl and 0.2 mmol/L EDTA. The amount of released
Ca2+ was determined as indicated in Section 2. One-way ANOVA
followed by Tukey’s post hoc test showed significant decrease of
Ca2+ efflux from mitochondria treated with CGP (***P < 0.001,
when compared to the control), significant increase of Ca2+ efflux
from mitochondria treated with PPT (only in NC mitochondria)
or DPN before CGP addition when compared to CGP alone (#P <
0.001), and significant increase of Ca2+ efflux from DPN + CGPtreated mitochondria when compared to PPT + CGP-treated
mitochondria (XP < 0.001). The results represent the mean ± SEM
of 4 experiments (with triplicate determinations).

energetic efficiency, ATP supply, free radical defense
system, and maintenance of Ca2+ homeostasis, E2
contributes to the preservation of mitochondrial
ultrastructure and membrane potential (Simpkins et al.,
2009; Richardson et al., 2012; Sastre-Serra et al., 2013).
Even more, E2 is known to reverse the damage of neural
cell mitochondria structure and ATP production caused
by gonadal hormone deficiency (Xu et al., 2008). Since
many of E2’s neuroprotective mechanisms converge
upon mitochondria (Nilsen et al., 2003), any insight into
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the pathways of E2 effects on mitochondrial function,
including their ability to accumulate and release Ca2+,
could be of particular interest. As we previously reported,
17β-estradiol acting in a nongenomic manner inhibits Ca2+
efflux from whole rat brain synaptosomal mitochondria,
as well as from synaptosomal mitochondria isolated
from specific brain regions: the hippocampus, NC, and
BS (Horvat et al., 2001; Petrovic et al., 2011, 2012). There
are 2 possible mechanisms of observed estradiol action:
one going through ERα/β localized in the mitochondrial
matrix (Chen et al., 2004; Psarra and Sekeris, 2009) and the
other, non-ER mediated, going through estrogen-specific
binding sites associated with mitochondrial membranes
(Moss et al., 1997). Our recent results on hippocampal
mitochondria speaking in favor of ER’s role in E2-induced
inhibition of mitochondrial Ca2+ efflux in this brain region
suggest that ER could be involved in transduction of E2
effects in 2 other brain regions, the NC and BS.
As expected, when isolated NC and BS synaptosomal
mitochondria were pretreated with ER antagonist ICI
182,780 to prevent E2 binding to ER, the inhibitory
effects of E2 and E-BSA on Ca2+ efflux were significantly
decreased (65%–80%), highlighting an important role for
ER in E2-induced modulation of mitochondrial Ca2+ flux.
As seen in the literature, ICI 182,780 is a potent inhibitor
of E2 action in the nervous system. Among others,
treatment with ICI 182,780 blocks E2’s effects on P2X3
receptor activity in sensory neurons (Ma et al., 2005), Akt1
activity in hippocampal CA1 neurons (Yang et al., 2010),
mitochondrial superoxide production in brain endothelial
cells (Razmara et al., 2008), and mitochondrial dysfunction
in astrocytes (Guo et al., 2012). Still, in our study, E2 and
E-BSA kept between 20%–35% of their inhibitory potential
even in the presence of ICI 182,780, suggesting that E2inhibition of mitochondrial Ca2+ efflux in the NC and BS
could at least partially be due to hormone action through
membrane binding-sites other than ERs. As previously
reported, E2 binds to an oligomycin-sensitive subunit of
the mitochondrial enzyme F0F1-ATPase (Ramirez et al.,
2001). Thus, by binding to such membrane-binding sites
near mtNCX, E2 may indirectly disrupt the function of
that transport protein.
However, our experiments with selective ERα agonist
PPT and ERβ agonist DPN confirmed the critical role
of ER in E2 action observed in this study. Both agonists
mimicked the inhibitory effect of E2 on Ca2+ efflux from
NC and BS mitochondria, although they were less effective.
On the other hand, DPN exerted stronger inhibitory
potential than PPT, suggesting the dominant role of ERβ.
In line with our results, ERβ mediated E2 reduction due
to ischemic damage in the NC of ovariectomized mice
(Carswell et al., 2004), while its agonist DPN decreased
the nitric oxide-mediated hypotensive effects of E2 in
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the rostral ventrolateral medulla of the BS (Shih, 2009).
Moreover, DPN enhances and PPT reduces ATP-evoked
response in nociceptive trigeminal BS neurons (Tashiro et
al., 2012). Further results in favor of ERβ were obtained
in experiments with selective mtNCX inhibitor CGP.
In our model system, Ca2+ efflux inhibition by CGP was
almost complete (>90%) when compared to the control.
In contrast to Ca2+ efflux inhibition by E2 in physiological
conditions, pretreatment with E2 significantly increased
mitochondrial Ca2+ efflux in the presence of CGP
(Petrovic et al., 2012). Moreover, in the current study,
in mitochondria isolated from both brain regions, DPN
protected mtNCX activity against CGP’s inhibitory action
in the same manner as E2, while ERα agonist PPT had a
weaker effect on NC and no effect on BS mitochondria.
The obtained results indicate for the first time that
ERα and ERβ participate in E2-induced modulation of
Ca2+ efflux from NC and BS synaptosomal mitochondria.
A dominant role of ERβ has been shown in mitochondria

from both brain regions. Since the experiments were
performed in vitro on isolated mitochondria, these findings
represent new evidence about genome-independent E2
effects in specific brain regions.
In summary, our study has shed light on the pathways
through which estradiol regulates mitochondrial
Ca2+ sequestration and consequently global cell Ca2+
homeostasis in the NC and BS. The role of ER has been
confirmed. Considering the vital role of Ca2+ in regulation
of total neural cell activity, from propagation of nerve
impulse to cell metabolism and apoptosis, the effects on
mitochondrial Ca2+ flux via ER could be the one of the
important routes of estradiol neuromodulatory action in
the brain.
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